Lisbeth M. Naess
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
FLU-v, a Broad-Spectrum Peptide-Based Influenza Vaccine, Induces NK Cell Activating IgG1 and IgG3 Subclass Antibodies in Humans.
Journal: Vaccines
Published: September 15, 2025
High-dimensional immune profiling identifies circulating NK and T cell subpopulations associated with asymptomatic COVID-19 and absence of multiple long-term symptoms.
Journal: Clinical immunology (Orlando, Fla.)
Published: May 30, 2025
Vaccination Against Meningococcal Disease in Children-A European Perspective.
Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: March 28, 2025
SARS-CoV-2 Infection With Alpha B.1.1.7 Virus Induced Higher Antibody Responses Than Earlier Non-VOC Variants During the First Waves of the COVID-19 Pandemic in Norway.
Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Published: March 14, 2025
"Why should I pay for this vaccine?" - Norwegian adolescents views on meningococcal vaccination.
Journal: BMC public health
Published: August 10, 2023
Genetic, Functional, and Immunogenic Analyses of the O-Linked Protein Glycosylation System in Neisseria meningitidis Serogroup A ST-7 Isolates.
Journal: Journal of bacteriology
Published: February 28, 2023
FLU-v, a Broad-Spectrum Influenza Vaccine, Induces Cross-Reactive Cellular Immune Responses in Humans Measured by Dual IFN-γ and Granzyme B ELISpot Assay.
Journal: Vaccines
Published: June 22, 2022
Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults.
Journal: Nature communications
Published: January 22, 2022
Household Transmission of SARS-CoV-2: A Prospective Longitudinal Study Showing Higher Viral Load and Increased Transmissibility of the Alpha Variant Compared to Previous Strains.
Journal: Microorganisms
Published: October 05, 2021
Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine.
Journal: Human vaccines & immunotherapeutics
Published: February 25, 2021
Last Updated: 09/26/2026